Old Web
English
Sign In
Acemap
>
authorDetail
>
Dimitrios Ziogas
Dimitrios Ziogas
University of Cambridge
Medicine
Pathology
Sorafenib
Liver disease
Hepatocellular carcinoma
4
Papers
6
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Considerations for the treatment of esophageal cancer during the COVID-19 pandemic
2021
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Spyridon Davakis
Michail Karamouzis
Dimitrios Ziogas
Alexandros Charalabopoulos
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problem.
2017
European Journal of Gastroenterology & Hepatology
Dimitrios Ziogas
Dionysios Papadatos-Pastos
Kiruthikah Thillai
Ippokratis Korantzis
Ruhe Chowdhury
Abid Suddle
John O’Grady
Gillian Al-Khadimi
Natalie Allen
Nigel Heaton
Paul Ross
Debashis Sarker
Show All
Source
Cite
Save
Citations (6)
Efficacy of sorafenib in patients with oligometastatic hepatoceulluar carcinoma (HCC).
2015
Journal of Clinical Oncology
Kiruthikah Thillai
Dimitrios Ziogas
Ippokratis Korantzis
Mh Ruhe Chowdhury
Dionysios Papadatos-Pastos
Abid Suddle
John O’Grady
Nigel Heaton
Paul Ross
Debashis Sarker
Show All
Source
Cite
Save
Citations (0)
Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC).
2015
Journal of Clinical Oncology
Dimitrios Ziogas
Kiruthikah Thillai
Ippokratis Korantzis
Mh Ruhe Chowdhury
Dionysios Papadatos-Pastos
Abid Suddle
John O’Grady
Nigel Heaton
Paul Ross
Debashis Sarker
Show All
Source
Cite
Save
Citations (0)
1